Photo used for illustrative purpose.
The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.
The European Medicines Agency's human medicines committee "has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years of age," the Amsterdam-based EMA said in a statement.
Evusheld consists of two monoclonal antibodies tixagevimab and cilgavimab — proteins designed to attack the spike protein of the Sars-CoV-2 virus, which causes COVID-19 — at two different sites, the EMA said.
It said data from a test on 5,000 people who were given two jabs, showed it reduced the risk of COVID-19 infection by 77 per cent and protection lasted for at least six months.
The study was done on adults who had never had COVID-19 and had never received a vaccine or other preventative treatment, the EMA said.
"The safety profile of Evusheld was favourable and side effects were generally mild, with a small number of people reporting reactions at the injection site or hypersensitivity," the medicines watchdog added.
But the study was done before the emergence of the infectious Omicron strain of the virus and "laboratory studies show that the Omicron BA.1 variant may be less sensitive to tixagevimab and cilgavimab than the Omicron BA.2 variant," the watchdog said.
The EMA's recommendation will now be forwarded to the European Commission for final approval before distribution to the 27-member bloc.
Evusheld received the US-based FDA's emergency authorisation in December.
The fresh suspensions were a major blow to a global immunisation campaign that experts hope will help end a year-long pandemic that has already killed over 2.6 million people and decimated the global economy.
Crossing the four million does mark comes as result of the efforts made at the country level to contain the pandemic, the Ministry of Health and Prevention announced on Friday.
The availability of vaccines is one of the biggest achievements of UAE. To all for free and in various centers, which requires everyone to take the vaccine to achieve the goal of covering 50% of UAE's population in the 1st quarter of 2021.
XPENG said on its Twitter, “GITEX, here we come! Our first group of XPENG X2 test pilots just took off for GITEX Global in sunny Dubai.￼
Minister of Tolerance and Co-Existence Sheikh Nahyan Bin Mubarak Al Nahyan has reiterated the commitment of the UAE leadership and its people to the pursuit of acceptance, forbearance, brotherliness and friendship.
In the details, a witness recorded in the video clip, a Kuwaiti citizen assaulting the worker, while he grabbed him by his clothes and beat him, shouting in his face, “a swindler.”
Sultan Ahmed Bin Sulayem, Chairman of the Ports, Customs and Free Zone Corporation, said: “We are working to achieve integration in our efforts to protect society from risks and facilitate trade movement not only at the local level but also at the global level, in cooperation with the security authorities in the relevant entities to present an international unique model that distinguishes Dubai on the world map”.